Everolimus Cumulative Dose and Dose Intensity in Pancreatic Neuroendocrine Tumors

被引：0
|
作者：
Berardi, R. [1 ]
Torniai, M. [1 ]
Pusceddu, S. [2 ]
Spada, F. [3 ]
Brizzi, M. P. [4 ]
Ibrahim, T. [5 ]
Antonuzzo, L. [6 ]
Ferolla, P. [7 ]
Panzuto, F. [8 ]
Silvestris, N. [9 ]
Partelli, S. [10 ]
Bongiovanni, A. [5 ]
Zichi, C. [4 ]
Riva, N. [5 ]
Rinzivillo, M. [8 ]
机构：
[1] Univ Politecn Marche, Ancona, Italy
[2] INT, Milan, Italy
[3] IEO, Milan, Italy
[4] San Luigi Hosp, Orbassano, Italy
[5] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Meldola, Italy
[6] AOU Careggi, Florence, Italy
[7] Osped S Maria Misericordia, Perugia, Italy
[8] Sapienza Univ Rome, St Andrea Hosp, Sch Med, Rome, Italy
[9] Cancer Inst Giovanni Paolo II, Bari, Italy
[10] Univ Vita & Salute, Osped San Raffaele IRCCS, Milan, Italy
来源：
NEUROENDOCRINOLOGY | 2016年 / 103卷
关键词：
PNET; Dose intensity; Targeted therapy; Everolimus; Cumulative dose;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
L2
引用
收藏
页码：77 / 77
页数：1
相关论文
共 50 条
  • [1] Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors
    Berardi, Rossana
    Torniai, Mariangela
    Pusceddu, Sara
    Spada, Francesca
    Ibrahim, Toni
    Brizzi, Maria Pia
    Antonuzzo, Lorenzo
    Ferolla, Piero
    Panzuto, Francesco
    Silvestris, Nicola
    Partelli, Stefano
    Ferretti, Benedetta
    Freddari, Federica
    Gucciardino, Calogero
    Testa, Enrica
    Concas, Laura
    Murgioni, Sabina
    Bongiovanni, Alberto
    Zichi, Clizia
    Riva, Nada
    Rinzivillo, Maria
    Brunetti, Oronzo
    Giustini, Lucio
    Di Costanzo, Francesco
    Delle Fave, Gianfranco
    Fazio, Nicola
    De Braud, Filippo
    Falconi, Massimo
    Cascinu, Stefano
    CANCER MEDICINE, 2017, 6 (07): : 1493 - 1499
  • [2] Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors (PNETs)
    Berardi, R.
    Pusceddu, S.
    Spada, F.
    Ibrahim, T.
    Brizzi, M. P.
    Antonuzzo, L.
    Ferolla, P.
    Rinzivillo, M.
    Silvestris, N.
    Freddari, F.
    Testa, E.
    Bongiovanni, A.
    Zichi, C.
    Di Costanzo, F.
    Delle Fave, G.
    Fazio, N.
    de Braud, F.
    Falconi, M.
    Cascinu, S.
    ANNALS OF ONCOLOGY, 2016, 27
  • [3] Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors (PNETs)
    Berardi, R.
    Torniai, M.
    Pusceddu, S.
    Spada, F.
    Ibrahim, T.
    Zichi, C.
    Antonuzzo, L.
    Ferolla, P.
    Rinzivillo, M.
    Silvestris, N.
    Partelli, S.
    Ferretti, B.
    Bongiovanni, A.
    Giustini, L.
    Di Costanzo, F.
    Delle Fave, G.
    Fazio, N.
    De Braud, F. G. M.
    Falconi, M.
    Cascinu, S.
    ANNALS OF ONCOLOGY, 2016, 27
  • [4] Clinical Impact of Everolimus Cumulative Dose on Pancreatic Neuroendocrine Tumors (pNETs) Outcome
    Berardi, R.
    Torniai, M.
    Onofri, A.
    Partelli, S.
    Guglielmi, S.
    Gucciardino, C.
    Savini, A.
    Ferretti, B.
    Enrica, T.
    Giustini, L.
    Falconi, M.
    Cascinu, S.
    NEUROENDOCRINOLOGY, 2014, 99 (3-4) : 275 - 275
  • [5] Sunitinib and everolimus in pancreatic neuroendocrine tumors
    Procopio, Giuseppe
    Pusceddu, Sara
    Buzzoni, Roberto
    TUMORI, 2012, 98 (03) : 394 - 394
  • [6] Role of everolimus in pancreatic neuroendocrine tumors
    Goldstein, Robert
    Meyer, Tim
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (11) : 1653 - 1665
  • [7] Everolimus for the treatment of pancreatic neuroendocrine tumors
    Feldmann, Georg
    Bisht, Savita
    Schuette, Ute
    Haarmann, Jens
    Brossart, Peter
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (14) : 2073 - 2084
  • [8] Everolimus for Advanced Pancreatic Neuroendocrine Tumors.
    Yao, James C.
    Shah, Manisha H.
    Ito, Tetsuhide
    Bohas, Catherine Lombard
    Wolin, Edward M.
    Van Cutsem, Eric
    Hobday, Timothy J.
    Okusaka, Takuji
    Capdevila, Jaume
    de Vries, Elisabeth G. E.
    Tomassetti, Paola
    Pavel, Marianne E.
    Hoosen, Sakina
    Haas, Tomas
    Lincy, Jeremie
    Lebwohl, David
    Oberg, Kjell
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (06): : 514 - 523
  • [9] Everolimus Effect on Gastrin and Glucagon in Pancreatic Neuroendocrine Tumors
    Pavel, Marianne E.
    Chen, David
    He, Wei
    Cushman, Stephanie
    Voi, Maurizio
    de Vries, Elisabeth G. E.
    Baudin, Eric
    Yao, James C.
    PANCREAS, 2017, 46 (06) : 751 - 757
  • [10] Everolimus in Advanced Pancreatic Neuroendocrine Tumors: The Clinical Experience
    Yao, James C.
    Phan, Alexandria T.
    Jehl, Valentine
    Shah, Gaurav
    Meric-Bernstam, Funda
    CANCER RESEARCH, 2013, 73 (05) : 1449 - 1453
12345